United States Liver Diseases Therapeutics Drugs Market Report 2017

January 2017 | 111 pages | ID: U2CB56BD5FAEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Liver Diseases Therapeutics Drugs

Revenue, means the sales value of Liver Diseases Therapeutics Drugs

This report studies sales (consumption) of Liver Diseases Therapeutics Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• F. Hoffmann-La Roche
• Gilead Sciences
• GlaxoSmithKline
• Johnson & Johnson
• Merck
• Achillion Pharmaceuticals,
• AbbVie
• Angion Biomedica
• Bayer
• LG Life Sciences
• Phenex Pharmaceuticals
• ProMetic Life Sciences
• Raptor Pharmaceuticals
• Shenzhen Kangtai Biological Products
• Verva Pharmaceuticals

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Oral
• Injection

Split by applications, this report focuses on sales, market share and growth rate of Liver Diseases Therapeutics Drugs in each application, can be divided into

• Hospital
• Clinic

Contents

United States Liver Diseases Therapeutics Drugs Market Report 2017

1 LIVER DISEASES THERAPEUTICS DRUGS OVERVIEW

1.1 Product Overview and Scope of Liver Diseases Therapeutics Drugs
1.2 Classification of Liver Diseases Therapeutics Drugs
  1.2.1 Oral
  1.2.2 Injection
1.3 Application of Liver Diseases Therapeutics Drugs
  1.3.1 Hospital
  1.3.2 Clinic
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Liver Diseases Therapeutics Drugs (2011-2021)
  1.4.1 United States Liver Diseases Therapeutics Drugs Sales and Growth Rate (2011-2021)
  1.4.2 United States Liver Diseases Therapeutics Drugs Revenue and Growth Rate (2011-2021)

2 UNITED STATES LIVER DISEASES THERAPEUTICS DRUGS COMPETITION BY MANUFACTURERS

2.1 United States Liver Diseases Therapeutics Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Liver Diseases Therapeutics Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Liver Diseases Therapeutics Drugs Average Price by Manufactures (2015 and 2016)
2.4 Liver Diseases Therapeutics Drugs Market Competitive Situation and Trends
  2.4.1 Liver Diseases Therapeutics Drugs Market Concentration Rate
  2.4.2 Liver Diseases Therapeutics Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES LIVER DISEASES THERAPEUTICS DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2011-2016)

3.1 United States Liver Diseases Therapeutics Drugs Sales and Market Share by States (2011-2016)
3.2 United States Liver Diseases Therapeutics Drugs Revenue and Market Share by States (2011-2016)
3.3 United States Liver Diseases Therapeutics Drugs Price by States (2011-2016)

4 UNITED STATES LIVER DISEASES THERAPEUTICS DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

4.1 United States Liver Diseases Therapeutics Drugs Sales and Market Share by Type (2011-2016)
4.2 United States Liver Diseases Therapeutics Drugs Revenue and Market Share by Type (2011-2016)
4.3 United States Liver Diseases Therapeutics Drugs Price by Type (2011-2016)
4.4 United States Liver Diseases Therapeutics Drugs Sales Growth Rate by Type (2011-2016)

5 UNITED STATES LIVER DISEASES THERAPEUTICS DRUGS SALES (VOLUME) BY APPLICATION (2011-2016)

5.1 United States Liver Diseases Therapeutics Drugs Sales and Market Share by Application (2011-2016)
5.2 United States Liver Diseases Therapeutics Drugs Sales Growth Rate by Application (2011-2016)
5.3 Market Drivers and Opportunities

6 UNITED STATES LIVER DISEASES THERAPEUTICS DRUGS MANUFACTURERS PROFILES/ANALYSIS

6.1 F. Hoffmann-La Roche
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Liver Diseases Therapeutics Drugs Product Type, Application and Specification
    6.1.2.1 Oral
    6.1.2.2 Injection
  6.1.3 F. Hoffmann-La Roche Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.1.4 Main Business/Business Overview
6.2 Gilead Sciences
  6.2.2 Liver Diseases Therapeutics Drugs Product Type, Application and Specification
    6.2.2.1 Oral
    6.2.2.2 Injection
  6.2.3 Gilead Sciences Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.2.4 Main Business/Business Overview
6.3 GlaxoSmithKline
  6.3.2 Liver Diseases Therapeutics Drugs Product Type, Application and Specification
    6.3.2.1 Oral
    6.3.2.2 Injection
  6.3.3 GlaxoSmithKline Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.3.4 Main Business/Business Overview
6.4 Johnson & Johnson
  6.4.2 Liver Diseases Therapeutics Drugs Product Type, Application and Specification
    6.4.2.1 Oral
    6.4.2.2 Injection
  6.4.3 Johnson & Johnson Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.4.4 Main Business/Business Overview
6.5 Merck
  6.5.2 Liver Diseases Therapeutics Drugs Product Type, Application and Specification
    6.5.2.1 Oral
    6.5.2.2 Injection
  6.5.3 Merck Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.5.4 Main Business/Business Overview
6.6 Achillion Pharmaceuticals,
  6.6.2 Liver Diseases Therapeutics Drugs Product Type, Application and Specification
    6.6.2.1 Oral
    6.6.2.2 Injection
  6.6.3 Achillion Pharmaceuticals, Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.6.4 Main Business/Business Overview
6.7 AbbVie
  6.7.2 Liver Diseases Therapeutics Drugs Product Type, Application and Specification
    6.7.2.1 Oral
    6.7.2.2 Injection
  6.7.3 AbbVie Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.7.4 Main Business/Business Overview
6.8 Angion Biomedica
  6.8.2 Liver Diseases Therapeutics Drugs Product Type, Application and Specification
    6.8.2.1 Oral
    6.8.2.2 Injection
  6.8.3 Angion Biomedica Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.8.4 Main Business/Business Overview
6.9 Bayer
  6.9.2 Liver Diseases Therapeutics Drugs Product Type, Application and Specification
    6.9.2.1 Oral
    6.9.2.2 Injection
  6.9.3 Bayer Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.9.4 Main Business/Business Overview
6.10 LG Life Sciences
  6.10.2 Liver Diseases Therapeutics Drugs Product Type, Application and Specification
    6.10.2.1 Oral
    6.10.2.2 Injection
  6.10.3 LG Life Sciences Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.10.4 Main Business/Business Overview
6.11 Phenex Pharmaceuticals
6.12 ProMetic Life Sciences
6.13 Raptor Pharmaceuticals
6.14 Shenzhen Kangtai Biological Products
6.15 Verva Pharmaceuticals

7 LIVER DISEASES THERAPEUTICS DRUGS MANUFACTURING COST ANALYSIS

7.1 Liver Diseases Therapeutics Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Liver Diseases Therapeutics Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Liver Diseases Therapeutics Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Liver Diseases Therapeutics Drugs Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES LIVER DISEASES THERAPEUTICS DRUGS MARKET FORECAST (2016-2021)

11.1 United States Liver Diseases Therapeutics Drugs Sales, Revenue Forecast (2016-2021)
11.2 United States Liver Diseases Therapeutics Drugs Sales Forecast by Type (2016-2021)
11.3 United States Liver Diseases Therapeutics Drugs Sales Forecast by Application (2016-2021)
11.4 Liver Diseases Therapeutics Drugs Price Forecast (2016-2021)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Liver Diseases Therapeutics Drugs
Table Classification of Liver Diseases Therapeutics Drugs
Figure United States Sales Market Share of Liver Diseases Therapeutics Drugs by Type in 2015
Figure Oral Picture
Figure Injection Picture
Table Application of Liver Diseases Therapeutics Drugs
Figure United States Sales Market Share of Liver Diseases Therapeutics Drugs by Application in 2015
Figure Hospital Examples
Figure Clinic Examples
Figure United States Liver Diseases Therapeutics Drugs Sales and Growth Rate (2011-2021)
Figure United States Liver Diseases Therapeutics Drugs Revenue and Growth Rate (2011-2021)
Table United States Liver Diseases Therapeutics Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Liver Diseases Therapeutics Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Liver Diseases Therapeutics Drugs Sales Share by Manufacturers
Figure 2016 Liver Diseases Therapeutics Drugs Sales Share by Manufacturers
Table United States Liver Diseases Therapeutics Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Liver Diseases Therapeutics Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Liver Diseases Therapeutics Drugs Revenue Share by Manufacturers
Table 2016 United States Liver Diseases Therapeutics Drugs Revenue Share by Manufacturers
Table United States Market Liver Diseases Therapeutics Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Liver Diseases Therapeutics Drugs Average Price of Key Manufacturers in 2015
Figure Liver Diseases Therapeutics Drugs Market Share of Top 3 Manufacturers
Figure Liver Diseases Therapeutics Drugs Market Share of Top 5 Manufacturers
Table United States Liver Diseases Therapeutics Drugs Sales by States (2011-2016)
Table United States Liver Diseases Therapeutics Drugs Sales Share by States (2011-2016)
Figure United States Liver Diseases Therapeutics Drugs Sales Market Share by States in 2015
Table United States Liver Diseases Therapeutics Drugs Revenue and Market Share by States (2011-2016)
Table United States Liver Diseases Therapeutics Drugs Revenue Share by States (2011-2016)
Figure Revenue Market Share of Liver Diseases Therapeutics Drugs by States (2011-2016)
Table United States Liver Diseases Therapeutics Drugs Price by States (2011-2016)
Table United States Liver Diseases Therapeutics Drugs Sales by Type (2011-2016)
Table United States Liver Diseases Therapeutics Drugs Sales Share by Type (2011-2016)
Figure United States Liver Diseases Therapeutics Drugs Sales Market Share by Type in 2015
Table United States Liver Diseases Therapeutics Drugs Revenue and Market Share by Type (2011-2016)
Table United States Liver Diseases Therapeutics Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Liver Diseases Therapeutics Drugs by Type (2011-2016)
Table United States Liver Diseases Therapeutics Drugs Price by Type (2011-2016)
Figure United States Liver Diseases Therapeutics Drugs Sales Growth Rate by Type (2011-2016)
Table United States Liver Diseases Therapeutics Drugs Sales by Application (2011-2016)
Table United States Liver Diseases Therapeutics Drugs Sales Market Share by Application (2011-2016)
Figure United States Liver Diseases Therapeutics Drugs Sales Market Share by Application in 2015
Table United States Liver Diseases Therapeutics Drugs Sales Growth Rate by Application (2011-2016)
Figure United States Liver Diseases Therapeutics Drugs Sales Growth Rate by Application (2011-2016)
Table F. Hoffmann-La Roche Basic Information List
Table F. Hoffmann-La Roche Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure F. Hoffmann-La Roche Liver Diseases Therapeutics Drugs Sales Market Share (2011-2016)
Table Gilead Sciences Basic Information List
Table Gilead Sciences Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Gilead Sciences Liver Diseases Therapeutics Drugs Sales Market Share (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Liver Diseases Therapeutics Drugs Sales Market Share (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Johnson & Johnson Liver Diseases Therapeutics Drugs Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Liver Diseases Therapeutics Drugs Sales Market Share (2011-2016)
Table Achillion Pharmaceuticals, Basic Information List
Table Achillion Pharmaceuticals, Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Achillion Pharmaceuticals, Liver Diseases Therapeutics Drugs Sales Market Share (2011-2016)
Table AbbVie Basic Information List
Table AbbVie Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table AbbVie Liver Diseases Therapeutics Drugs Sales Market Share (2011-2016)
Table Angion Biomedica Basic Information List
Table Angion Biomedica Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Angion Biomedica Liver Diseases Therapeutics Drugs Sales Market Share (2011-2016)
Table Bayer Basic Information List
Table Bayer Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Liver Diseases Therapeutics Drugs Sales Market Share (2011-2016)
Table LG Life Sciences Basic Information List
Table LG Life Sciences Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table LG Life Sciences Liver Diseases Therapeutics Drugs Sales Market Share (2011-2016)
Table Phenex Pharmaceuticals Basic Information List
Table ProMetic Life Sciences Basic Information List
Table Raptor Pharmaceuticals Basic Information List
Table Shenzhen Kangtai Biological Products Basic Information List
Table Verva Pharmaceuticals Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Liver Diseases Therapeutics Drugs
Figure Manufacturing Process Analysis of Liver Diseases Therapeutics Drugs
Figure Liver Diseases Therapeutics Drugs Industrial Chain Analysis
Table Raw Materials Sources of Liver Diseases Therapeutics Drugs Major Manufacturers in 2015
Table Major Buyers of Liver Diseases Therapeutics Drugs
Table Distributors/Traders List
Figure United States Liver Diseases Therapeutics Drugs Production and Growth Rate Forecast (2016-2021)
Figure United States Liver Diseases Therapeutics Drugs Revenue and Growth Rate Forecast (2016-2021)
Table United States Liver Diseases Therapeutics Drugs Production Forecast by Type (2016-2021)
Table United States Liver Diseases Therapeutics Drugs Consumption Forecast by Application (2016-2021)
Table United States Liver Diseases Therapeutics Drugs Sales Forecast by States (2016-2021)
Table United States Liver Diseases Therapeutics Drugs Sales Share Forecast by States (2016-2021)